Pulmonx 10-Q: Cash Falls to $52.7M, Perceptive Debt at 14% Effective Rate
LUNG has more than doubled off its 52-week low of $1.13.
Summary
Pulmonx's Q3 10-Q shows cash down to $52.7 million from $69.8 million at year-end, a $40.5 million Perceptive loan at a 14.0% effective rate, and revenue covenants that start at $85 million against $66.2 million booked in nine months.
Key Events · Earnings and Guidance · LUNG
-
Q3 Revenue Up 6% to $22.8M
Third-quarter revenue rose 6.2% to $22.8 million from $21.5 million, and the net loss narrowed to $8.4 million from $14.0 million on a $5.6 million cut in SG&A.
-
Cash Burn Leaves $52.7M
Cash and equivalents fell to $52.7 million at September 30, 2026 from $69.8 million at December 31, 2025, after $18.5 million of operating cash use in the first nine months.
-
Perceptive Loan Costs 14% Effective
The $40.0 million Perceptive term loan carries a 14.0% effective rate and replaced the $37.0 million CIBC loan repaid in March 2026; interest expense rose to $3.4 million for nine months from $2.4 million.
-
Revenue Covenants Loom
Perceptive requires minimum trailing revenue of $85.0 million rising to $107.5 million by December 31, 2030, plus $4.0 million minimum unrestricted cash; the company was in compliance at September 30, 2026.
Analysis · LUNG · Industrial Applications And Services
The headline numbers were already out on October 27, but the full 10-Q shows how thin the cushion is getting. Cash dropped from $69.8 million to $52.7 million in nine months while operations burned $18.5 million, and the company now carries a $40.5 million Perceptive term loan at a 14.0% effective rate after retiring the cheaper CIBC facility. Management says existing cash funds at least 12 months, but the Perceptive covenants require trailing revenue starting at $85 million and climbing to $107.5 million by 2030, against $66.2 million booked in the first nine months. Add 1.5 million warrants to Perceptive and new 10b5-1 selling plans from a director and the chief commercial officer, and the equity story leans on a China restart and continued cost cuts.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LUNG was trading at $2.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $116.8M. The 52-week trading range was $1.13 to $3.25. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.